AI Analysis AI Analysis of NPCE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NPCE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Is NeuroPace, Inc. stock still a buy after falling -6.25% on Friday?
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 17, 2026 Loss -19.84%

The NeuroPace, Inc. stock price fell by -6.25% on the last day (Friday, 31st Jul 2026) from $13.75 to $12.89. During the last trading day the stock fluctuated 8.53% from a day low at $12.66 to a day high of $13.74. The price has been going up and down for this period, and there has been a -19.84% loss for the last 2 weeks. Volume has increased on the last day by 104 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 332 thousand shares were bought and sold for approximately $4.28 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($13.86) are considered to be a "second chance" to get out. According to the fan-theory $10.10 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

NPCE Signals & Forecast

There are few to no technical positive signals at the moment. The NeuroPace, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.34 and $15.75. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -27.58%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for NeuroPace, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.08 between high and low, or 8.53%. For the last week, the stock has had daily average volatility of 6.17%.

NeuroPace, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NPCE) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect NeuroPace, Inc. to open at $13.10, and during the day (based on 14 day Average True Range), to move between $12.47 and $13.31, which gives a possible trading interval of +/-$0.85 (+/-6.81%) up or down from last closing price. If NeuroPace, Inc. takes out the full calculated possible swing range there will be an estimated 6.81% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $14.68, some $1.79 (13.89%) from the current price of $12.89, our system finds the risk reward not very attractive.

Is NeuroPace, Inc. stock A Buy?

NeuroPace, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -7.752 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $13.10 ( 1.60%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NPCE Performance

Trading levels for NPCE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 14.18 9.98%
R2 13.76 6.78%
R1 13.51 4.80%
Price 12.89
S1 12.68 -1.60%
S2 12.43 -3.57%
S3 12.02 -6.78%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.81 22.65%
R2 15.67 21.57%
R1 14.68 13.89%
Price 12.89
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for NeuroPace, Inc. Stock and on which exchange is it traded?
The symbol for NeuroPace, Inc. is NPCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroPace, Inc. Stock?
NeuroPace, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy NeuroPace, Inc. Stock?
NeuroPace, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroPace, Inc. Stock.

What's the current price of NeuroPace, Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an NeuroPace, Inc. (NPCE) share was $12.89.

What is the 52-week high and low for NeuroPace, Inc. Stock?
The 52-week high for NeuroPace, Inc. Stock is $19.60 and the 52-week low is $7.56.

What is the market capitalization of NeuroPace, Inc. Stock?
As of the Jul 31, 2026, the market capitalization of NeuroPace, Inc. is 439.468M.

When is the next earnings date for NeuroPace, Inc.?
The upcoming earnings date for NeuroPace, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT NEUROPACE, INC.
NeuroPace
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE